| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC COM | 4,382,764 | 306,793,000 | 84.52% | ||
| 2 | Agile Therapeutics, Inc. | 5,062,363 | 35,335,000 | 9.73% | ||
| 3 | IMMUNE DESIGN CORP COM | 1,962,720 | 14,877,000 | 4.10% | ||
| 4 | ANTHERA PHARMACEUTICALS I | 1,900,000 | 5,985,000 | 1.65% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134211, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
